Showing results (11-20 of 38) with videos related to
Sort By:
Pageof 4
Cancer Letters|May 28, 2003
Nuclear delivery of p53 C-terminal peptides into cancer cells using scFv fragments of a monoclonal antibody that penetrates living cellsRichard H Weisbart, Carl W Miller, Grace Chan, et al.Oncology Reports|December 6, 2005
SAHA, a HDAC inhibitor, has profound anti-growth activity against non-small cell lung cancer cellsNaoki Komatsu, Norihiko Kawamata, Seisho Takeuchi, et al.International Journal of Cancer|December 14, 2006
FOXA1: Growth inhibitor and a favorable prognostic factor in human breast cancerIdo Wolf, Shikha Bose, Elizabeth A Williamson, et al.Oncogene|November 26, 2002
Methylation, expression, and mutation analysis of the cell cycle control genes in human brain tumorsDong Yin, Dong Xie, Wolf-Karsten Hofmann, et al.Oncology Reports|July 14, 2005
Do cancer cells selectively mutate HFE to increase their intracellular iron?Claudia I Müller, Carl W Miller, Hiroshi Kawabata, et al.Cancer|July 14, 2011
Xeroderma pigmentosum complementation group C single-nucleotide polymorphisms in the nucleotide excision repair pathway correlate with prolonged progression-free survival in advanced ovarian cancerNicole D Fleming, Hasmik Agadjanian, Hoorig Nassanian, et al.International Journal of Oncology|March 11, 2004
Imprinting status of DLK1 gene in brain tumors and lymphomasDong Yin, Dong Xie, Sven De Vos, et al.Oncogene|April 13, 2004
Cyr61 suppresses the growth of non-small-cell lung cancer cells via the beta-catenin-c-myc-p53 pathwayXiangjun Tong, James O'Kelly, Dong Xie, et al.The Journal of Biological Chemistry|October 9, 2004
Cyr61 suppresses growth of human endometrial cancer cellsWenwen Chien, Takashi Kumagai, Carl W Miller, et al.International Journal of Oncology|December 5, 2006
KLF6: mutational analysis and effect on cancer cell proliferationDong Yin, Naoki Komatsu, Carl W Miller, et al.Pageof 4